1. Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer

2. American Cancer Society. Cancer Facts & Figures 2020. Atlanta: American Cancer Society; 2020. Available from https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2020/cancer-facts-and-figures-2020.pdf.Accessed January 27, 2020.

3. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: prostate cancer version 1.2020. Available from: https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf. Accessed May 20, 2020.

4. Mottet N, van den Bergh RCN, Briars E, et al. Prostate cancer guidelines 2019. Available from: https://uroweb.org/guideline/prostate-cancer/. Accessed January 27, 2020.

5. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer